Voriconazole (injection): Difference between revisions
Jump to navigation
Jump to search
Ahmed Zaghw (talk | contribs) No edit summary |
Ahmed Zaghw (talk | contribs) No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Voriconazole}} | {{Voriconazole}} | ||
{{CMG}} | '''''For patient information, click <u>[[Voriconazole (patient information)|here]]</u>'''''. | ||
{{CMG}}; {{AE}} {{AZ}} | |||
==Overview== | ==Overview== | ||
==Category== | ==Category== | ||
Antifungal drug | |||
==US Brand Names== | ==US Brand Names== | ||
'''Vfend<sup>®</sup>''' | |||
==FDA Package Insert== | ==FDA Package Insert== | ||
| Line 28: | Line 30: | ||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
[[Category:Antibiotics]] | [[Category:Antibiotics]] | ||
[[Category:Wikinfect]] | [[Category:Wikinfect]] | ||
Revision as of 06:22, 9 January 2014
For patient information, click here.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Zaghw, M.D. [2]
Overview
Category
Antifungal drug
US Brand Names
Vfend®
FDA Package Insert
Description | Clinical Pharmacology | Microbiology | Indications and Usage | Contraindications | Warnings and Precautions | Adverse Reactions | Drug Interactions | Overdosage | Clinical Studies | Dosage and Administration | How Supplied | Labels and Packages